Page 88 - GPD-3-3

Gene & Protein in Disease Next gen (omics)

3. Schork NJ. The big data revolution and human genetics. 11. Naik H, Palaniappan L, Ashley EA, Scott SA. Digital health
Hum Mol Genet. 2018;27(R1):R1. applications for pharmacogenetic clinical trials. Genes
(Basel). 2020;11(11):1261.
doi: 10.1093/hmg/ddy123
doi: 10.3390/genes11111261
4. Cazzaniga A, Plebani M, Crimi M. Genome access and other
web-based IT solutions: Genetic counseling in the digital 12. Stein DJ, Giordano J. Global mental health and neuroethics.
era. Front Public Health. 2022;10:1035316. BMC Med. 2015;13(1):44.
doi: 10.3389/fpubh.2022.1035316 doi: 10.1186/s12916-015-0274-y
5. Dasho E, Kuneshka L, Toci E. Information technology in 13. Koido K, Traks T, Balõtšev R, et al. Associations between
health-care systems and primary health care. Open Access LSAMP gene polymorphisms and major depressive disorder
Maced J Med Sci. 2022;10(E):1919-1926. and panic disorder. Transl Psychiatry. 2012;2(8):e152.
doi: 10.3889/oamjms.2022.11380 doi: 10.1038/tp.2012.74
6. Brennan J, McElligott A, Power N. National Health models 14. Ho XD, Phung P, Le VQ, et al. Whole transcriptome
and the adoption of E-health and E-prescribing in primary analysis identifies differentially regulated networks between
care - New evidence from Europe. J Innov Health Inform. osteosarcoma and normal bone samples. Exp Biol Med
2015;22(4):399-408. (Maywood). 2017;242(18):1802-1811.
doi: 10.14236/jhi.v22i4.97 doi: 10.1177/1535370217736512
7. Reale R, Biasin E, Scardovi A, Toro S. The design and 15. Bandrés‐Ciga S, Ahmed S, Sabir MS, et al. The genetic
implementation of a national AI platform for public architecture of Parkinson disease in Spain: Characterizing
healthcare in Italy: Implications for semantics and population‐specific risk, differential haplotype
interoperability. arXiv [Preprint]. 2023. structures, and providing etiologic insight. Mov Disord.
2019;34(12):1851-1863.
doi: 10.48550/arxiv.2304.11893
doi: 10.1002/mds.27864
8. Andersson D, Kebede FT, Escobar M, Österlund T,
Ståhlberg A. Principles of digital sequencing using unique 16. Smith CE, Fullerton SM, Dookeran KA, et al. Using genetic
molecular identifiers. Mol Aspects Med. 2024;96:101253. technologies to reduce, rather than widen, health disparities.
Health Aff (Millwood). 2016;35(8):1367-1373.
doi: 10.1016/j.mam.2024.101253
doi: 10.1377/hlthaff.2015.1476
9. Abdallah S, Sharifa M, Almadhoun MKI, et al. The impact of
artificial intelligence on optimizing diagnosis and treatment 17. Belani S, Tiarks GC, Mookerjee N, Rajput V. “I agree to
plans for rare genetic disorders. Cureus. 2023;15(10):e46860. disagree”: Comparative ethical and legal analysis of big data
and genomics for privacy, consent, and ownership. Cureus.
doi: 10.7759/cureus.46860
2021;13(10):e18736.
10. Miao BY, Sushil M, Xu A, et al. Characterisation of
digital therapeutic clinical trials: A systematic review doi: 10.7759/cureus.18736
with natural language processing. Lancet Digit Health. 18. Karabekmez ME. Data ethics in digital health and genomics.
2024;6(3):e222-e229. New Bioeth. 2021;27(4):320-333.
doi: 10.1016/s2589-7500(23)00244-3 doi: 10.1080/20502877.2021.1996965

Volume 3 Issue 3 (2024) 6 doi: 10.36922/gpd.4128